Newsletter Archive

  1. 07.23.14 -- Scientists Design Immunosignatures As Early Cancer Diagnostic; Standing Wave Acts as Invisible Cell Filter
    7/23/2014

    07/23/14 Bioresearch Online Newsletter

  2. 07.21.14 -- White House, WHO Commit To Global Action Plan On Antimicrobial Resistance
    7/21/2014

    07/21/14 Bioresearch Online Newsletter

  3. 07.16.14 -- FDA Approval Pushes Novartis Into 21st Century Vaccine Development
    7/16/2014

    07/16/14 Bioresearch Online Newsletter

  4. 07.14.14 -- Analytical QbD At Teva; Deploying Smart Process Sensors Sensibly
    7/14/2014

    07/14/14 Bioresearch Online Newsletter

  5. 07.09.14 -- Transcept And Paratek Sign Merger Agreement; FDA Grants Priority Review To Boehringer Ingelheim's Nintedanib NDA
    7/9/2014

    07/09/14 Bioresearch Online Newsletter

  6. 07.07.14 -- Albumin Addresses Need For Better And Longer-Lasting Drugs
    7/7/2014

    07/07/14 Bioresearch Online Newsletter

  7. 07.02.14 -- EMD Serono And Mersana Enter ADC Collaboration; FDA's First Draft Guidance Under DSCSA
    7/2/2014

    07/02/14 Bioresearch Online Newsletter

  8. 06.30.14 -- Stanford Scientists Find Way To Quicken Drug Discovery; FDA Approval Pushes Novartis Into 21st Century Vaccine Development
    6/30/2014

    06/30/14 Bioresearch Online Newsletter

  9. UK Puts Dementia Drug Research On The Fast Track; Asmacure Reports Positive Phase 1/2a Data For Asthma Drug
    6/25/2014
    UK Puts Dementia Drug Research On The Fast Track; Asmacure Reports Positive Phase 1/2a Data For Asthma Drug
  10. 06.23.14 -- AstraZeneca And ADDC Announce Drug Development Collaboration
    6/23/2014

    06/23/14 Bioresearch Online Newsletter

Newsletter Signup
Newsletter Signup